Twilight Dark-Adaptation Device Now Available in US - Takeaways - MDSpire

Twilight Dark-Adaptation Device Now Available in US

Evoq Technologies receives official FDA registration as a Class I medical device

By
mdspire news news staff
December 1, 2025
1 min

Ophthalmology Management

Share

1

Evoq Technologies has received FDA registration for its Twilight dark-adaptation testing instrument as a Class I medical device.
2

Twilight is designed to detect age-related macular degeneration, diabetic eye disease, and inherited retinal disease.
3

The device allows technicians to screen for eye diseases without requiring dark rooms or pupil dilation.
4

Testing with Twilight is reimbursable under CPT 92284 for eligible patients.
5

Daniel Lindgren, CEO of Evoq Technologies, claims Twilight changes the diagnostic standard of care for eye diseases.

Original Source(s)

Ophthalmology Management

Twilight Dark-Adaptation Device Now Available in US

by mdspire news news staff
December 1, 2025

Related Content

MDSpire News

Can Oral Gildeuretinol Slow Advanced Macular Degeneration?

Although the trial missed its primary endpoint, exploratory analyses suggested slower lesion growth and better functional outcomes with gildeuretinol.